SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-014929
Filing Date
2024-02-16
Accepted
2024-02-16 16:36:43
Documents
17
Period of Report
2024-02-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193985-8k_fresh2group.htm   iXBRL 8-K 31655
2 AMENDMENT TO THE SEPTEMBER 25, 2023 CONVERTIBLE NOTES, DATED FEBRUARY 15, 2024 ea193985ex4-1_fresh2group.htm EX-4.1 11964
3 AMENDMENT TO THE DECEMBER 6, 2023 CONVERTIBLE NOTES, DATED FEBRUARY 15, 2024 ea193985ex4-2_fresh2group.htm EX-4.2 11683
  Complete submission text file 0001213900-24-014929.txt   278174

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fres-20240215.xsd EX-101.SCH 3863
5 XBRL DEFINITION FILE fres-20240215_def.xml EX-101.DEF 26768
6 XBRL LABEL FILE fres-20240215_lab.xml EX-101.LAB 37014
7 XBRL PRESENTATION FILE fres-20240215_pre.xml EX-101.PRE 25392
18 EXTRACTED XBRL INSTANCE DOCUMENT ea193985-8k_fresh2group_htm.xml XML 5476
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 8-K | Act: 34 | File No.: 001-39137 | Film No.: 24648986
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)